Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study

This study compares conventional hazard ratios and an alternative, clinically interpretable approach to quantify the long-term survival benefit in patients receiving chemotherapy with immunotherapy.

https://ift.tt/2JPlGdn